Acumen Pharmaceuticals In...
(ABOS)
undefined
undefined%
At close: undefined
2.03
0.00%
After-hours Dec 13, 2024, 04:00 PM EST
Company Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease.
The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers.
Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Acumen Pharmaceuticals Inc.
Country | United States |
IPO Date | Jul 1, 2021 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 51 |
CEO | Daniel J. O'Connell M.B.A. |
Contact Details
Address: 427 Park Street Charlottesville, Virginia United States | |
Website | https://acumenpharm.com |
Stock Details
Ticker Symbol | ABOS |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001576885 |
CUSIP Number | 00509G209 |
ISIN Number | US00509G2093 |
Employer ID | 36-4108129 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Daniel J. O'Connell M.B.A. | Chief Executive Officer & Director |
Derek M. Meisner Esq., J.D. | Chief Legal Officer & Corporate Secretary |
Matt Zuga | Chief Financial Officer & Chief Business Officer |
Russell Barton M.S. | Chief Operating Officer |
Alex Braun M.B.A. | Vice President & Head of Investor Relations |
Dr. Caleb E. Finch Ph.D. | Co-Founder |
Dr. Grant A. Krafft Ph.D. | Co-Founder |
Dr. James Doherty Ph.D. | President & Chief Development Officer |
Dr. William L. Klein Ph.D. | Co-Founder |
Kelly Carranza | Vice President, Finance & Accounting and Corporate Controller |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 12, 2024 | 10-Q | Quarterly Report |
Nov 06, 2024 | 4 | Filing |
Nov 06, 2024 | 3 | Filing |
Aug 13, 2024 | 10-Q | Quarterly Report |
Aug 13, 2024 | 8-K | Current Report |
Jun 10, 2024 | 4 | Filing |
Jun 10, 2024 | 4 | Filing |
Jun 10, 2024 | 4 | Filing |
Jun 10, 2024 | 4 | Filing |
Jun 10, 2024 | 4 | Filing |